Agilent Technologies (A) Capital Expenditures (2009 - 2026)
Agilent Technologies (A) posted quarterly Capital Expenditures of $76.0 million for Q2 2026, down 33.33% year-over-year from $114.0 million in Q2 2025, and down 18.28% quarter-over-quarter from $93.0 million in Q1 2026.
Agilent Technologies (A) Capital Expenditures (2009 - 2026) Analysis & Trends
Agilent Technologies (A) has reported Capital Expenditures for 18 consecutive years, with $76.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Capital Expenditures fell 33.33% year-over-year to $76.0 million; the TTM figure through Apr 2026 stood at $365.0 million (down 7.83% YoY), while the FY2025 annual figure was $407.0 million, up 7.67% from the prior year.
- Capital Expenditures fell to $76.0 million in Q2 2026 per A's latest filing, from $93.0 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $114.0 million in Q2 2025 and bottomed at $57.0 million in Q2 2023.
- Historically, Capital Expenditures has averaged $85.7 million across 5 years, with a median of $87.0 million in 2023.
- Annual changes were most pronounced in 2022 — Capital Expenditures surged 106.45% — and 2026, when it plunged 33.33%.
- Agilent Technologies' Capital Expenditures stood at $70.0 million in 2022, then rose by 20.0% to $84.0 million in 2023, then rose by 10.71% to $93.0 million in 2024, then changed by 0.0% to $93.0 million in 2025, then retreated by 18.28% to $76.0 million in 2026.
- Business Quant data shows A's Capital Expenditures at $76.0 million in Q2 2026, $93.0 million in Q1 2026, and $93.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 450.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 269.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 63.43 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 76.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 198.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 24.65 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 40.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 27.79 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 131.60 Mn |
| 10 | Quest Diagnostics | 27.10 Bn | 26.47 Bn | 1.03 Bn | 138.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 76.00 Mn |
| Apr 30, 2026 | 76.00 Mn |
| Jan 31, 2026 | 93.00 Mn |
| Jan 31, 2026 | 93.00 Mn |
| Oct 31, 2025 | 93.00 Mn |
| Oct 31, 2025 | 93.00 Mn |
| Jul 31, 2025 | 103.00 Mn |
| Jul 31, 2025 | 103.00 Mn |
| Apr 30, 2025 | 114.00 Mn |
| Apr 30, 2025 | 114.00 Mn |
| Jan 31, 2025 | 97.00 Mn |
| Jan 31, 2025 | 97.00 Mn |
| Oct 31, 2024 | 93.00 Mn |
| Oct 31, 2024 | 93.00 Mn |
| Jul 31, 2024 | 92.00 Mn |
| Jul 31, 2024 | 92.00 Mn |
| Apr 30, 2024 | 103.00 Mn |
| Apr 30, 2024 | 103.00 Mn |
| Jan 31, 2024 | 90.00 Mn |
| Jan 31, 2024 | 90.00 Mn |